ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Organon


Include trials that are no longer recruiting patients.

6 studies were found.
1.RecruitingFondaparinux Use in a Broad Range of Patients with ST-segment Elevation Acute Myocardial Infarction (MI)
Condition: Myocardial Infarction
2.CompletedA safety and efficacy trial evaluating the use of fondaparinux in percutaneous coronary intervention (PCI)
Conditions: Myocardial Infarction; Coronary Disease
3.RecruitingA safety and efficacy trial evaluating the use of SanOrg34006 compared to placebo in patients who have completed 6 months of treatment for symptomatic pulmonary embolism or deep vein thrombosis
Conditions: Pulmonary Embolism; Deep Vein Thrombosis
4.RecruitingA safety and efficacy trial evaluating the use of SanOrg34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation
Condition: Atrial Fibrillation
5.RecruitingA safety and efficacy trial evaluating the use of SanOrg34006 in the treatment of pulmonary embolism
Condition: Pulmonary Embolism
6.No longer recruitingSafety Study of Fondaparinux Sodium to Prevent Venous Thromboembolic Events (APOLLO)
Condition: Venous Thrombosis

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act